Oxiracetam NEW
| Price | $50 | $76 | $118 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: Oxiracetam | CAS No.: 62613-82-5 |
| Purity: 99.69% | Supply Ability: 10g |
| Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | Oxiracetam |
| Description | Oxiracetam (ISF2522), a cyclic derivative of gamma-aminobutyric acid (GABA), is utilized for the treatment of cognitive impairments. |
| In vitro | In BALB/c mice, Oxiracetam (50 mg/kg i.p.) has been shown to improve avoidance acquisition. Similarly, in rats, pretreatment with Oxiracetam (30 mg/kg) has demonstrated efficacy in ameliorating cognitive deficits induced by trimethyltin. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 10 mg/mL (63.23 mM), Sonication is recommended. |
| Keywords | γ-Aminobutyric acid Receptor | Oxiracetam | ISF-2522 | ISF 2522 | Inhibitor | inhibit | Gamma-aminobutyric acid Receptor | GABAReceptor | GABAR | GABA Receptor |
| Inhibitors Related | 2-Isopropyl-1H-imidazole | p-Hydroxybenzaldehyde | Urethane | Penicillin G sodium salt | Aminopicoline | Valproic Acid | Agmatine sulfate | Methylene Blue trihydrate | Methyl eugenol | Gluconate Calcium | Dihydromyricetin | Magnesium sulfate |
| Related Compound Libraries | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Neuroprotective Compound Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Ion Channel Targeted Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-07-20 | ||
|
VIP3Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2026-07-20 | ||
| $1000.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2026-07-16 | |
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-07-16 | ||
| $161.00 |
VIP6Y
|
Baoji Guokang Healthchem Co., Ltd.
|
2026-07-15 | |
|
VIP1Y
|
Rongchuang International
|
2026-07-08 | ||
| $1.80 |
VIP5Y
|
Hebei Dangtong Import and export Co LTD
|
2026-07-01 | |
| $50.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2026-04-10 | ||
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY